v2.4.0.6
Condensed Consolidated Statements of Operations (Unaudited) (USD $)
3 Months Ended 173 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2013
Revenue      
Sales     $ 2,994,931
Cost of sales     3,325,639
Gross Loss     (330,708)
Operating Expenses      
Depreciation     52,694
Selling, general and administration 272,741 155,824 13,617,859
Market development   42,562 927,940
Product development costs 125,123 122,075 4,240,882
Professional fees 63,327 40,343 2,076,951
Total Operating Expenses 461,191 360,804 20,916,326
Operating Loss (461,191) (360,804) (21,247,034)
Other Expenses (Income)      
Interest expenses 301,247 482,689 25,073,284
Write-down of equipment     36,623
Other expenses (income) (17,548) (40,228) 248,676
Total Other Expenses 283,699 442,461 25,358,583
Net Loss $ (744,890) $ (803,265) $ (46,605,617)
Weighted average shares outstanding, - basic and diluted (in Shares) 237,455,687 213,977,909